Assessment of stroke risk in Middle Eastern patients with atrial fibrillation: The gulf SAFE registry

International Journal of Cardiology

Volumn 168, Issue 2, 2013, Pages 1644-1646

  Apostolakis, S ^a   Zubaid, M ^b   Rashed, W A ^c   Alsheikh Ali, A A ^d,e   Almahmeed, W ^d   Shehab, A ^f   Sulaiman, K ^g   AlQudaimi, A ^h   Asaad, N ⁱ   Amin, H ^j   Lane, D A ^a   Lip, G Y H ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b KUWAIT UNIVERSITY   (Kuwait)

^c MUBARAK AL KABEER HOSPITAL   (Kuwait)

^d SHEIKH KHALIFA MEDICAL CITY   (United Arab Emirates)

^e TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^g ROYAL HOSPITAL   (Oman)

^h Al Thawra Hospital   (Yemen)

ⁱ HAMAD MEDICAL CORPORATION   (Qatar)

^j BAHRAIN DEFENCE FORCE HOSPITAL   (Bahrain)

more..

Author keywords

Atrial fibrillation; Middle East; Thromboembolism

Indexed keywords

AGE; BRAIN EMBOLISM; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CLINICAL ASSESSMENT TOOL; CONGESTIVE HEART FAILURE; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DISEASE REGISTRY; ELECTROCARDIOGRAM; GENDER; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; INTERMETHOD COMPARISON; LETTER; MIDDLE EAST; OUTCOMES RESEARCH; PATIENT CODING; PRIORITY JOURNAL; RISK ASSESSMENT; THROMBOEMBOLISM; TRANSIENT ISCHEMIC ATTACK; VALIDATION PROCESS;

ATRIAL FIBRILLATION; CHA(2)DS(2)-VASC; CHADS(2); MIDDLE EAST; THROMBOEMBOLISM;

AGED; ATRIAL FIBRILLATION; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERNATIONALITY; MALE; MIDDLE EAST; PROSPECTIVE STUDIES; REGISTRIES; RISK FACTORS; STROKE;

EID: 84885331730     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.02.003     Document Type: Article

References (8)

1. Lip GY, Tse HF, Lane DA. Atrial fibrillation. Lancet 2012;379:648-61.
2. European Heart Rhythm Association, European Association for Cardio-Thoracic SurgeryCamm AJ, et al. Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Europace 2010;12:1360-420.
3. ZubaidM, RashedWA, Alsheikh-Ali AA, et al. Gulf Survey of Atrial Fibrillation Events (Gulf SAFE): design and baseline characteristics of patients with atrial fibrillation In the Arab Middle East. Circ Cardiovasc Qual Outcomes 2011;4:477-82.
4. Pencina MJ, D'Agostino RB, Vasan RS. Statistical methods for assessment of added usefulness of new biomarkers. Clin Chem Lab Med 2010;48:1703-11.
5. Vickers AJ, Elkin EB. Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making 2006;26:565-74.
6. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 2001;285:2864-70.
7. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism In atrial fibrillation using a novel risk factorbased approach: the Euro Heart Survey on atrial fibrillation. Chest 2010;137:263-72.
8. Al Rashdan I, Al Nesef Y. Prevalence of overweight, obesity, and metabolic syndrome among adult Kuwaitis: results from community-based national survey. Angiology 2010;61:42-8.